Orphan designation recommended for BTK inhibitorFebruary 26, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
How an anticancer drug fights lymphoid malignanciesFebruary 23, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaNon-Hodgkin Lymphoma
Teens’ weight, height linked to risk of NHLFebruary 22, 2016Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Risk of reproductive problems in male cancer survivorsFebruary 19, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated Issues
Drug shows promise for treating resistant AML, MCLFebruary 17, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLNon-Hodgkin Lymphoma
Combo can produce durable remissions in PTCLFebruary 12, 2016Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Method may reduce toxicity of anticancer agentsFebruary 11, 2016Lymphoma & Plasma Cell DisordersRelated Issues
Chemo regimen can be ‘highly effective’ against ENKTLFebruary 10, 2016Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Immunotherapy proves active against MF, SSFebruary 5, 2016Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
FDA approves drug for patients receiving MECFebruary 5, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyRelated Issues
Mutations may impact response to HDACis in PTCL-NOSFebruary 4, 2016Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Lenalidomide shows promise for treating ATLLFebruary 3, 2016Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
EHA creates ‘roadmap’ for hematology researchFebruary 3, 2016CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaThrombosisBlood Banking
Study suggests chidamide could treat rel/ref CTCL tooFebruary 2, 2016Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma